A Self-Guided Mobile Mindfulness Intervention Embedded in Daily Routines for Adults With Mild to Moderate Psychological Distress: Randomized Controlled Trial
STAT+: Swing Therapeutics acquired by medical VR platform XR Health
Swing Therapeutics, developer of a Food and Drug Administration-cleared digital treatment for fibromyalgia, has been acquired by medical virtual reality company XR Health.
Swing is XR Health’s sixth acquisition in the last two years and finds the VR developer taking a new business direction as it aims to be a go-to source of digital treatments for disease. The terms of the deal were not disclosed because, as XR Health CEO Eran Orr explained, “it won’t be the last” acquisition for the company.
XR Health, Orr claimed, has dozens of different apps on its platform currently and delivered a million user sessions in 2025. Offerings include a range of meditation and cognitive behavioral therapy-based VR experiences targeted at mental health issues, pain, hot flashes, and more. XR Health’s large packages of VR treatments are registered with the FDA but not cleared.
Working Mechanisms and Effectiveness of IV Ketamine-assisted Psychotherapy on Depression in TRD Clients
Sponsors: Senz; Radboud University Medical Center
Recruiting
Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder
Interventions: Drug: TREATMENT ARM: Full dose; Drug: CONTROL ARM: Active-controlled
Sponsors: U.S. Army Medical Research and Development Command; Resilient Pharmaceuticals; Walter Reed National Military Medical Center; Congressionally Directed Medical Research Programs
Not yet recruiting
Digital Mindfulness-Based Therapy for Obsessive-Compulsive Disorder
Interventions: Behavioral: Digital Mindfulness-Based Therapy; Drug: Routine Pharmacological Treatment
Sponsors: Central South University; Second Xiangya Hospital of Central South University
Not yet recruiting
Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive Disorder
Interventions: Drug: Psilocybin; Behavioral: Structured Integrated Reframing Therapy (SIRT); Drug: Selective Serotonin Reuptake Inhibitor (SSRI)
Sponsors: Khyber Medical University Peshawar; Hayatabad Medical Complex; KMU Institute of Health Science, Islamabad
Recruiting
Rehabilitation, Education, and SElf-management for Adolescents After Mild Traumatic Brain Injury
Interventions: Behavioral: Mindfulness-based intervention; Behavioral: Health Education
Sponsors: Molly Cairncross
Not yet recruiting

